• 1. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 2. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 3. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837

Introduction to 3(2H)-Pyridazinone,6-hydroxy-, Potassium Salt (1:1) and Its Significance in Modern Chemical Biology

The compound with the CAS number 28382-15-2, identified as 3(2H)-Pyridazinone,6-hydroxy-, Potassium Salt (1:1), represents a fascinating molecule with profound implications in the field of chemical biology. This potassium salt derivative of 3(2H)-pyridazinone, characterized by its hydroxyl group and ionic form, has garnered significant attention due to its unique structural and functional properties. The integration of this compound into various biochemical pathways and its potential applications in drug discovery underscore its importance in contemporary research.

3(2H)-Pyridazinone is a heterocyclic organic compound that serves as a versatile scaffold in medicinal chemistry. The presence of the hydroxyl group at the 6-position and the potassium counterion at a 1:1 ratio enhances its solubility and reactivity, making it an attractive candidate for further chemical modifications. These modifications can be tailored to explore new pharmacophores or enhance specific biological activities, thereby expanding its utility in therapeutic interventions.

The potassium salt form of 6-hydroxy-3(2H)-pyridazinone is particularly noteworthy for its role in stabilizing the molecule's structure while maintaining its bioactive properties. This stability is crucial for pharmaceutical applications, where consistency and efficacy are paramount. The hydroxyl group also provides a site for hydrogen bonding interactions, which are essential for binding to biological targets such as enzymes and receptors.

Recent advancements in chemical biology have highlighted the importance of heterocyclic compounds like 3(2H)-Pyridazinone,6-hydroxy-, Potassium Salt (1:1) in developing novel therapeutic agents. For instance, studies have demonstrated that derivatives of pyridazinone exhibit inhibitory effects on various enzymes involved in metabolic pathways. These pathways are often dysregulated in diseases such as diabetes, cancer, and inflammatory disorders. By targeting these enzymes, compounds like 3(2H)-Pyridazinone,6-hydroxy-, Potassium Salt (1:1) could potentially modulate these pathways and alleviate associated symptoms.

In the realm of drug discovery, the potassium salt form offers additional advantages. Its ionic nature facilitates interactions with polar biological molecules, enhancing its bioavailability and pharmacokinetic properties. This makes it an ideal candidate for oral administration or other routes of delivery where charge-based interactions play a critical role.

The structural versatility of 3(2H)-Pyridazinone,6-hydroxy-, Potassium Salt (1:1) also allows for the exploration of different functional groups that can be incorporated into the molecule. These modifications can be designed to optimize binding affinity, metabolic stability, and other pharmacological parameters. Such flexibility is invaluable in medicinal chemistry, where achieving the right balance between potency and safety is essential.

Current research is increasingly focusing on harnessing the potential of heterocyclic compounds like 3(2H)-Pyridazinone,6-hydroxy-, Potassium Salt (1:1) for therapeutic purposes. For example, recent studies have shown that certain pyridazinone derivatives exhibit anti-inflammatory properties by inhibiting key pro-inflammatory cytokines. This aligns with the growing interest in developing targeted therapies that address the root causes of inflammation rather than merely alleviating symptoms.

The potassium salt form's solubility also makes it suitable for formulation into various drug delivery systems. Advanced techniques such as nanoparticle encapsulation or lipid-based carriers can enhance its bioavailability and targeted delivery to specific tissues or organs. These innovations are critical for improving therapeutic outcomes and reducing side effects associated with conventional drug formulations.

Moreover, the hydroxyl group in 3(2H)-Pyridazinone,6-hydroxy-, Potassium Salt (1:1) provides a unique opportunity for further chemical derivatization. By introducing different substituents at this position, researchers can fine-tune the molecule's properties to achieve desired biological effects. This approach has been successfully employed in developing novel antibiotics, antivirals, and anticancer agents.

The broader significance of this compound lies in its potential to contribute to our understanding of biochemical mechanisms at a molecular level. By studying how 3(2H)-Pyridazinone,6-hydroxy-, Potassium Salt (1:1) interacts with biological targets, scientists can gain insights into disease pathogenesis and identify new therapeutic strategies. This knowledge is invaluable for advancing personalized medicine approaches that take into account individual genetic variations.

In conclusion,3(2H)-Pyridazinone, 6-hydroxy-, Potassium Salt (1:1), with its CAS number 28382-15-2, represents a promising compound with diverse applications in chemical biology and drug discovery. Its unique structural features and functional properties make it an ideal candidate for further research aimed at developing novel therapeutic agents. As our understanding of biochemical pathways continues to evolve,3(2H)-Pyridazinone, 6-hydroxy-, Potassium Salt (1:1) is poised to play a significant role in addressing some of the most pressing challenges in modern medicine.

• 3538-81-6((2E)-but-2-enedihydrazide)
• 63307-81-3( )
• 51137-11-2(3,6-Pyridazinedione, 1,2-dihydro-, ammonium salt)
• 63355-02-2(1,2-dihydropyridazine-3,6-dione;nickel)
• 63307-76-6(3,6-Pyridazinedione,1,2-dihydro-, manganese(2+) salt (2:1))
• 123-33-1(Maleic hydrazide)
• 14628-35-4(2-Butenedioicacid (2Z)-, 1,4-dihydrazide)
• 67298-03-7(2,4-Hexadienoic acid, 2-(1-oxo-2,4-hexadienyl)hydrazide)
• 62607-62-9(2-Butenoic acid, hydrazide)
• 63307-78-8(Cobalt;1,2-dihydropyridazine-3,6-dione)